Lista de obras -

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

artículo científico publicado en 2017

A Phase III Randomized, Double-Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: North Central Cancer Treatment Group Study N04CA ⬇️

artículo científico publicado el 1 de mayo de 2011

A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy

artículo científico publicado en 2016

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

artículo científico publicado en 2007

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)

artículo científico publicado en 2010

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

artículo científico publicado en 2009

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775

artículo científico publicado en 2012

Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study

artículo científico publicado en 2014

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

artículo científico publicado en 2019

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

scientific article published on 20 March 2020

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

artículo científico publicado en 2017

Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Melanoma

artículo científico publicado en 2020

Brachial Plexus Neuritis Associated With Anti-Programmed Cell Death-1 Antibodies: Report of 2 Cases

scientific article published on 01 September 2017

Cancer immunotherapy in patients with preexisting rheumatologic disease: the Mayo Clinic experience.

artículo científico publicado en 2018

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

artículo científico publicado en 2019

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

artículo científico publicado en 2020

Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).

scientific article published on 15 January 2016

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

artículo científico publicado en 2008

Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial

artículo científico publicado en 2020

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma

artículo científico publicado en 2006

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

artículo científico publicado en 2006

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

artículo científico publicado en 2016

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma

scientific article published on 01 December 2016

Fluctuation of systemic immunity in melanoma and implications for timing of therapy ⬇️

artículo científico publicado el 1 de enero de 2012

Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management

artículo científico publicado en 2017

Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations

artículo científico publicado en 2020

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases

artículo científico publicado en 2015

In-transit melanoma: an individualized approach

artículo científico publicado el 1 de diciembre de 2011

Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors

artículo científico publicado en 2018

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

artículo científico publicado en 2017

Ipilimumab-induced colitis in patients with metastatic melanoma

artículo científico publicado en 2015

Levetiracetam for the treatment of hot flashes: a phase II study

artículo científico publicado en 2007

Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis

artículo científico publicado en 2007

Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment

artículo científico publicado en 2007

Melanoma brain metastases and vemurafenib: need for further investigation

artículo científico publicado en 2012

Metastatic malignant melanoma.

artículo científico publicado en 2009

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.

artículo científico publicado en 2017

Neoadjuvant systemic therapy for regionally advanced melanoma.

artículo científico publicado en 2017

Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy

artículo científico publicado en 2014

Nursing's presence in the changing cooperative group setting

artículo científico

PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients

artículo científico publicado en 2020

Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

artículo científico publicado en 2017

Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma

scientific article published on 05 August 2020

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

artículo científico publicado en 2009

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

artículo científico publicado en 2014

Pilot evaluation of aprepitant for the treatment of hot flashes

artículo científico publicado en 2006

Pilot evaluation of flaxseed for the management of hot flashes.

artículo científico publicado en 2007

Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine ⬇️

artículo científico publicado el 1 de octubre de 2011

Promoting Oral Therapy Adherence: Consensus Statements From the Faculty of the Melanoma Nursing Initiative on Oral Melanoma Therapies

Rare presentations of primary melanoma and special populations: a systematic review

artículo científico publicado en 2014

Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma

artículo científico publicado en 2016

Rheumatic syndromes associated with immune-checkpoint inhibitors: a single-center cohort of 61 patients

artículo científico publicado en 2019

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era.

artículo científico publicado en 2017

Second response to the letter to the editor referencing the manuscript the "use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial"

artículo científico publicado en 2012

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

artículo científico publicado en 2019

Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort

scientific article published on 27 February 2020

Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)

artículo científico publicado en 2015

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

artículo científico publicado en 2017

T cell Bim levels reflect responses to anti-PD-1 cancer therapy.

artículo científico publicado en 2016

The Future of Immunotherapy in the Treatment of Cancer

scientific article published on 30 August 2019

The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.

scientific article published on June 2015

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

scientific article published on 30 January 2019

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 ⬇️

artículo científico publicado el 13 de noviembre de 2012

The use of pembrolizumab for the treatment of metastatic uveal melanoma

artículo científico publicado en 2016

The use of pulsed dye laser in the treatment of melanoma metastatic to the skin: a Mayo Clinic case series

artículo científico publicado en 2010

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial ⬇️

artículo científico publicado el 9 de octubre de 2010

Vemurafenib for Melanoma Metastases to the Brain ⬇️

artículo científico publicado el 22 de diciembre de 2011

Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trial

scientific article published on 01 September 2007

Lista de obras de

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

A Phase III Randomized, Double-Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: North Central Cancer Treatment Group Study N04CA ⬇️

A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775

Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Melanoma

Brachial Plexus Neuritis Associated With Anti-Programmed Cell Death-1 Antibodies: Report of 2 Cases

Cancer immunotherapy in patients with preexisting rheumatologic disease: the Mayo Clinic experience.

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma

Fluctuation of systemic immunity in melanoma and implications for timing of therapy ⬇️

Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management

Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases

In-transit melanoma: an individualized approach

Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Ipilimumab-induced colitis in patients with metastatic melanoma

Levetiracetam for the treatment of hot flashes: a phase II study

Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis

Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment

Melanoma brain metastases and vemurafenib: need for further investigation

Metastatic malignant melanoma.

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.

Neoadjuvant systemic therapy for regionally advanced melanoma.

Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy

Nursing's presence in the changing cooperative group setting

PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients

Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Pilot evaluation of aprepitant for the treatment of hot flashes

Pilot evaluation of flaxseed for the management of hot flashes.

Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine ⬇️

Promoting Oral Therapy Adherence: Consensus Statements From the Faculty of the Melanoma Nursing Initiative on Oral Melanoma Therapies

Rare presentations of primary melanoma and special populations: a systematic review

Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma

Rheumatic syndromes associated with immune-checkpoint inhibitors: a single-center cohort of 61 patients

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era.

Second response to the letter to the editor referencing the manuscript the "use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial"

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort

Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

T cell Bim levels reflect responses to anti-PD-1 cancer therapy.

The Future of Immunotherapy in the Treatment of Cancer

The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 ⬇️

The use of pembrolizumab for the treatment of metastatic uveal melanoma

The use of pulsed dye laser in the treatment of melanoma metastatic to the skin: a Mayo Clinic case series

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial ⬇️

Vemurafenib for Melanoma Metastases to the Brain ⬇️

Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trial